Terns Pharmaceuticals Net Income vs. Market Capitalization
| TERN Stock | USD 35.97 0.69 1.88% |
Net Loss | First Reported 2019-12-31 | Previous Quarter -24.1 M | Current Value -24.6 M | Quarterly Volatility 6.9 M |
For Terns Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Terns Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Terns Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Terns Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Terns Pharmaceuticals over time as well as its relative position and ranking within its peers.
Check out World Market Map. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Terns Pharmaceuticals Market Capitalization vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Terns Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Terns Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Terns Pharmaceuticals is rated fourth in net income category among its peers. It is currently regarded as top stock in market capitalization category among its peers . Terns Pharmaceuticals reported last year Net Loss of (79.97 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Terns Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Terns Market Capitalization vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Terns Pharmaceuticals |
| = | (88.85 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Terns Pharmaceuticals |
| = | 3.98 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Terns Market Capitalization vs Competition
Terns Pharmaceuticals is currently regarded as top stock in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 16.73 Billion. Terns Pharmaceuticals totals roughly 3.98 Billion in market capitalization claiming about 24% of equities under Health Care industry.
Terns Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Terns Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Terns Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Terns Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Terns Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -251.1 K | -263.7 K | |
| Net Interest Income | 15.3 M | 16 M | |
| Interest Income | 15.3 M | 16 M | |
| Operating Income | -91.7 M | -96.3 M | |
| Net Loss | -80 M | -84 M | |
| Income Before Tax | -79.7 M | -83.7 M | |
| Total Other Income Expense Net | 15.3 M | 16 M | |
| Net Loss | -54.3 M | -57 M | |
| Net Loss | -80 M | -84 M | |
| Income Tax Expense | 299 K | 328.6 K | |
| Non Operating Income Net Other | 1.8 M | 1.6 M | |
| Change To Netincome | 12.4 M | 13 M | |
| Net Loss | (1.01) | (1.06) | |
| Income Quality | 0.91 | 0.92 | |
| Net Income Per E B T | 0.90 | 0.80 |
Terns Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Terns Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Terns Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Terns Pharmaceuticals' important profitability drivers and their relationship over time.
Terns Pharmaceuticals Earnings Estimation Breakdown
The calculation of Terns Pharmaceuticals' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Terns Pharmaceuticals is estimated to be -0.3033 with the future projection ranging from a low of -0.34 to a high of -0.25. Please be aware that this consensus of annual earnings estimates for Terns Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.34 Lowest | Expected EPS | -0.25 Highest |
Terns Pharmaceuticals Earnings Projection Consensus
Suppose the current estimates of Terns Pharmaceuticals' value are higher than the current market price of the Terns Pharmaceuticals stock. In this case, investors may conclude that Terns Pharmaceuticals is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Terns Pharmaceuticals' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 10 | 50.0% | 0.0 | -0.3033 | -1.02 |
Terns Pharmaceuticals Earnings per Share Projection vs Actual
Actual Earning per Share of Terns Pharmaceuticals refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Terns Pharmaceuticals predict the company's earnings will be in the future. The higher the earnings per share of Terns Pharmaceuticals, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Terns Pharmaceuticals Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Terns Pharmaceuticals, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Terns Pharmaceuticals should always be considered in relation to other companies to make a more educated investment decision.Terns Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Terns Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-10 | 2025-09-30 | -0.3021 | -0.27 | 0.0321 | 10 | ||
2025-08-05 | 2025-06-30 | -0.2918 | -0.26 | 0.0318 | 10 | ||
2025-05-12 | 2025-03-31 | -0.2702 | -0.26 | 0.0102 | 3 | ||
2025-03-12 | 2024-12-31 | -0.3002 | -0.24 | 0.0602 | 20 | ||
2024-11-12 | 2024-09-30 | -0.32 | -0.28 | 0.04 | 12 | ||
2024-08-05 | 2024-06-30 | -0.34 | -0.31 | 0.03 | 8 | ||
2024-05-13 | 2024-03-31 | -0.34 | -0.3 | 0.04 | 11 | ||
2024-03-14 | 2023-12-31 | -0.29 | -0.29 | 0.0 | 0 | ||
2023-11-14 | 2023-09-30 | -0.31 | -0.42 | -0.11 | 35 | ||
2023-08-08 | 2023-06-30 | -0.34 | -0.25 | 0.09 | 26 | ||
2023-05-15 | 2023-03-31 | -0.27 | -0.31 | -0.04 | 14 | ||
2023-03-27 | 2022-12-31 | -0.43 | -0.29 | 0.14 | 32 | ||
2022-11-09 | 2022-09-30 | -0.52 | -0.44 | 0.08 | 15 | ||
2022-08-08 | 2022-06-30 | -0.59 | -0.55 | 0.04 | 6 | ||
2022-05-16 | 2022-03-31 | -0.64 | -0.55 | 0.09 | 14 | ||
2022-03-03 | 2021-12-31 | -0.63 | -0.56 | 0.07 | 11 | ||
2021-11-15 | 2021-09-30 | -0.6 | -0.47 | 0.13 | 21 | ||
2021-08-16 | 2021-06-30 | -0.71 | -0.43 | 0.28 | 39 | ||
2021-05-14 | 2021-03-31 | -0.77 | -0.88 | -0.11 | 14 | ||
2021-03-30 | 2020-12-31 | -0.91 | -30.94 | -30.03 | 3300 |
Use Terns Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Terns Pharmaceuticals Pair Trading
Terns Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Terns Pharmaceuticals position
In addition to having Terns Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 500 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
To fully project Terns Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Terns Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Terns Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.